This test is most useful if any of these apply to you.
A fever after time in tick habitat can be anaplasmosis even when your first antibody result is negative. This screen looks for an immune response to Anaplasma phagocytophilum. Its usefulness depends on when you became ill and whether the result agrees with your symptoms and other findings.
A positive screen can reflect a current infection, a past infection or antibodies that react with a related organism. It can't establish when an infection happened or prove that a recent tick bite transmitted it.
IgG stands for immunoglobulin G. After an infection resolves, these antibodies can stay in circulation for weeks to years, and the duration varies from person to person. Anaplasma phagocytophilum lives inside neutrophils. These white blood cells help fight infection. The illness the bacterium causes is called human granulocytic anaplasmosis, or HGA.
This screen detects IgG antibodies in serum using indirect immunofluorescence, or IFA. Serum is the liquid left after blood clots. The lab exposes diluted serum to cells containing the bacterium and uses a fluorescent reagent to reveal antibody binding under a microscope.
The screen reports whether antibodies are detected. A reactive sample can undergo a separate titer measurement, which records how far the serum can be diluted while the reaction remains visible. That titer is an estimate of antibody reactivity, not an exact antibody concentration. The screen itself has no numerical level to trend.
The CDC treats IgG IFA as the reference standard for confirming anaplasmosis with antibody testing, especially when titers from an illness and recovery are compared. It is insensitive in the first week of illness and becomes highly sensitive two to three weeks after symptoms start.
The illness usually starts with fever, headache, muscle aches and a general sense of being unwell. Blood work often shows low platelets, low white cell counts and raised liver enzymes. Severe illness can include kidney failure, respiratory failure and failure of several organs.
In U.S. surveillance from 2008 through 2012, about three in a thousand reported cases with known outcomes were fatal. Older age, a weakened immune system, conditions such as diabetes and delayed treatment increase the risk of severe illness. This risk comes from the infection; an antibody result doesn't grade its severity.
In a medical-record study of 465 people with PCR-confirmed anaplasmosis, hospitalized people were more often older or immunocompromised and had more underlying illness. Only about a quarter had all three commonly described laboratory findings together: low white cells, low platelets and raised liver enzymes. Missing one part of that pattern is common.
Antibodies also turn up in healthy people. Their frequency varies with geography, past exposure and the assay used. Studies that count positive antibody results don't necessarily count confirmed infections.
| Who Was Studied | How Antibodies Were Assessed | What They Found |
|---|---|---|
| People in 56 studies worldwide | Pooled antibody surveys across different populations and testing approaches | Antibody positivity was about 5% in healthy populations and 14% in groups considered at higher risk |
| 301 healthy blood donors in western Norway | Serum IgG measured by indirect immunofluorescence | About one in six had a positive result |
| About 10,000 U.S. military personnel | ELISA screening followed by Western blot testing, different methods from this IFA screen | About 2.6% were reactive by ELISA, while 0.11% were positive by Western blot |
The Norwegian study measured the same antibody class in serum by IFA. The global review pooled broader antibody evidence, and the military study used different assays. Their percentages cannot be used as the accuracy of this screen or as your personal chance of infection. The large difference between the military study's two methods also shows why a reactive screening result needs context.
A study in Sweden and the Åland Islands followed 90 people after tick bites using serum IgG IFA. Thirty had been bitten by ticks carrying Anaplasma. Only one participant developed a fourfold antibody rise over three months, and that person reported no symptoms. Their submitted tick had tested negative for Anaplasma, so the antibody change couldn't be attributed to transmission from a known infected tick. This small study doesn't establish the risk from an infected tick in every region.
The immune response takes time. IgG IFA is frequently negative during the first week of illness, when the bacterium may already be detectable by a whole-blood PCR test. PCR looks for bacterial DNA. Only about a quarter to a half of people have detectable antibodies when they first seek care.
In a small New York study of infections confirmed by PCR and culture, IgG IFA detected antibodies in only around half of the samples taken during illness but in nearly all recovery samples. The study supports comparing illness and recovery samples, but its small size and selected cases limit how precisely it estimates performance in everyday use.
A change from not detected to detected can support a recent immune response when the illness and timing fit. A fourfold rise in paired IgG IFA titers provides stronger evidence of recent infection. Those are related findings, but a change in the screen result alone doesn't establish a fourfold rise.
Over longer periods, persistent positivity can reflect immune memory. Antibody results are not a reliable way to measure treatment success or decide whether an infection has cleared.
Evidence-backed interventions that affect your A. Phagocytophilum IgG Screen level
A. Phagocytophilum IgG Screen is best interpreted alongside these tests.
A. Phagocytophilum IgG Screen is included in these pre-built panels.
See whether a tick may have left you with anaplasmosis, and whether the exposure looks recent or long past.